Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bodyport is a digital health company focused on the remote management of complex chronic conditions, particularly heart failure and kidney disease. The company's primary product is the Bodyport Cardiac Scale, a non-invasive sensor-integrated platform that measures key hemodynamic indicators such as fluid status and cardiac function during a daily weigh-in. By utilizing advanced algorithms to detect early signs of worsening health, Bodyport enables clinicians to intervene proactively, potentially reducing hospitalizations and improving patient outcomes. The system integrates seamlessly into a patient's daily routine, providing a simple yet powerful tool for longitudinal health monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Body.